LPS Signaling in Macrophages: The Roll of Toll

Information

  • Research Project
  • 9517651
  • ApplicationId
    9517651
  • Core Project Number
    R01AI032972
  • Full Project Number
    5R01AI032972-28
  • Serial Number
    032972
  • FOA Number
    PAS-15-055
  • Sub Project Id
  • Project Start Date
    7/1/1992 - 32 years ago
  • Project End Date
    6/30/2021 - 3 years ago
  • Program Officer Name
    JIANG, CHAO
  • Budget Start Date
    7/1/2018 - 6 years ago
  • Budget End Date
    6/30/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    28
  • Suffix
  • Award Notice Date
    6/20/2018 - 6 years ago

LPS Signaling in Macrophages: The Roll of Toll

The innate immune system is the first line of defense against pathogens. Innate immune cells lack the exquisite specificity of the adaptive immune system, yet in order to respond in a measured way, they must be able to tailor their activity to the specific pathogen. These cells have therefore evolved pattern recognition receptors (PRRs) that recognize conserved molecules characteristic of the microbe, which are not found within the host. The Toll-like receptors (TLRs) are the archetypal PRRs. The innate immune response to viruses occurs principally by inducing type I interferons (IFN). It has recently been appreciated that IFN also functions in the response to bacteria, although its role here is poorly defined. We have shown that 25-HC, an oxysterol which is derived enzymatically from cholesterol by Ch25h, has a role in regulating the inflammatory response and immunity. Ch25h is strongly induced by both TLR2-activation and by IFN, and we have further demonstrated that 25-HC reciprocally impacts both of these pathways: It amplifies and sustains a subset of the TLR-induced inflammatory genes while simultaneously suppressing expression of a subset of interferon- stimulated genes. Therefore, Ch25h is an immune modulator situated at the intersection of these two major pathways, the precise regulation of which is crucial to controlling viral and bacterial infections such as Listeria monocytogenes and Mycobacterium tuberculosis. We propose to identify the molecular mechanisms by which 25-HC impacts TLR and IFN responses and determine the role of these interactions in control of bacterial infections. We will first define the mechanism by which 25-HC amplifies TLR2 signaling in macrophages by examining the mechanism by which 25-HC suppresses IL-10 production and determining the role of 25-HC- mediated epigenetic regulation in altering expression of TLR2 induced genes. Next we will determine the mechanisms by which 25-HC regulates crosstalk between interferon and inflammatory signaling. Here we shall determine the mechanism by which 25-HC mediates the suppression of IFN-stimulated genes. We shall then determine the role of 25-HC in cross-regulation between innate immune pathways. Finally, we will determine the role of 25-HC in macrophage control of Listeria monocytogenes in vitro and in vivo.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    523877
  • Indirect Cost Amount
    502922
  • Total Cost
    1026799
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:1026799\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    III
  • Study Section Name
    Innate Immunity and Inflammation Study Section
  • Organization Name
    SEATTLE BIOMEDICAL RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    070967955
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981095240
  • Organization District
    UNITED STATES